[
  {
    "id": "study-001",
    "title": "Treating Depression with Transcutaneous Auricular Vagus Nerve Stimulation: State of the Art and Future Perspectives",
    "authors": "Kong et al.",
    "journal": "Frontiers in Psychiatry",
    "year": 2018,
    "condition": "Depression",
    "studyType": "narrative review",
    "subjects": null,
    "keyFinding": "Transcutaneous auricular VNS shows promise as a non-invasive treatment for depression, with evidence of antidepressant effects through modulation of brain networks including the default mode network.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/29459836/",
    "doi": "https://doi.org/10.3389/fpsyt.2018.00020",
    "stimulationType": "taVNS",
    "tags": ["depression", "taVNS", "review", "mental health"]
  },
  {
    "id": "study-002",
    "title": "Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial",
    "authors": "Handforth et al.",
    "journal": "Neurology",
    "year": 1998,
    "condition": "Epilepsy",
    "studyType": "RCT",
    "subjects": 254,
    "keyFinding": "High-stimulation VNS produced a significantly greater reduction in seizure frequency (28%) compared to low-stimulation controls (15%) in drug-resistant epilepsy.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/9674777/",
    "doi": "https://doi.org/10.1212/WNL.51.1.48",
    "stimulationType": "iVNS",
    "tags": ["epilepsy", "iVNS", "seizures", "drug-resistant"]
  },
  {
    "id": "study-003",
    "title": "Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: a nonrandomized controlled pilot study",
    "authors": "Rong et al.",
    "journal": "Journal of Affective Disorders",
    "year": 2016,
    "condition": "Depression",
    "studyType": "pilot",
    "subjects": 160,
    "keyFinding": "Four weeks of taVNS significantly reduced Hamilton Depression Rating Scale scores compared to sham, with a response rate of 37.5% versus 12.5% in controls.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/26896810/",
    "doi": "https://doi.org/10.1016/j.jad.2016.02.031",
    "stimulationType": "taVNS",
    "tags": ["depression", "taVNS", "pilot", "mental health"]
  },
  {
    "id": "study-004",
    "title": "Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study",
    "authors": "Tassorelli et al.",
    "journal": "Neurology",
    "year": 2018,
    "condition": "Migraine",
    "studyType": "RCT",
    "subjects": 248,
    "keyFinding": "Non-invasive cervical VNS was safe and well-tolerated for acute migraine treatment, though the primary endpoint of pain-free status at 2 hours did not reach significance versus sham.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/29907608/",
    "doi": "https://doi.org/10.1212/WNL.0000000000005857",
    "stimulationType": "tcVNS",
    "tags": ["migraine", "tcVNS", "acute treatment", "headache", "PRESTO"]
  },
  {
    "id": "study-005",
    "title": "Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis",
    "authors": "Koopman et al.",
    "journal": "Proceedings of the National Academy of Sciences",
    "year": 2016,
    "condition": "Inflammation",
    "studyType": "pilot",
    "subjects": 17,
    "keyFinding": "Implanted VNS significantly inhibited TNF production and improved clinical signs in rheumatoid arthritis patients, providing direct evidence of the inflammatory reflex in humans.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/27382171/",
    "doi": "https://doi.org/10.1073/pnas.1605635113",
    "stimulationType": "iVNS",
    "tags": ["inflammation", "iVNS", "rheumatoid arthritis", "cytokines", "TNF"]
  },
  {
    "id": "study-006",
    "title": "Safety of transcutaneous auricular vagus nerve stimulation (taVNS): a systematic review and meta-analysis",
    "authors": "Kim et al.",
    "journal": "Scientific Reports",
    "year": 2022,
    "condition": "Safety",
    "studyType": "systematic review",
    "subjects": 6322,
    "keyFinding": "Across 177 studies and 6,322 subjects, taVNS was generally well-tolerated with mild and transient side effects. Serious adverse events were rare and not clearly attributable to stimulation.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/36543841/",
    "doi": "https://doi.org/10.1038/s41598-022-25864-1",
    "stimulationType": "taVNS",
    "tags": ["safety", "taVNS", "systematic review", "meta-analysis", "tolerability"]
  },
  {
    "id": "study-007",
    "title": "Effect of Transcutaneous Vagus Nerve Stimulation at Auricular Concha for Insomnia: A Randomized Clinical Trial",
    "authors": "Jiao et al.",
    "journal": "Evidence-Based Complementary and Alternative Medicine",
    "year": 2020,
    "condition": "Sleep",
    "studyType": "RCT",
    "subjects": 72,
    "keyFinding": "Four weeks of taVNS significantly improved Pittsburgh Sleep Quality Index scores and sleep efficiency in patients with chronic insomnia compared to sham stimulation.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/32831871/",
    "doi": "https://doi.org/10.1155/2020/6049891",
    "stimulationType": "taVNS",
    "tags": ["sleep", "insomnia", "taVNS", "RCT"]
  },
  {
    "id": "study-008",
    "title": "Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children",
    "authors": "Orosz et al.",
    "journal": "Epilepsia",
    "year": 2014,
    "condition": "Epilepsy",
    "studyType": "long-term study",
    "subjects": 347,
    "keyFinding": "Long-term VNS in paediatric epilepsy showed progressive improvement over 24 months, with 32% of patients achieving at least 50% seizure reduction.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/25231724/",
    "doi": "https://doi.org/10.1111/epi.12762",
    "stimulationType": "iVNS",
    "tags": ["epilepsy", "paediatric", "iVNS", "long-term"]
  },
  {
    "id": "study-009",
    "title": "Transcutaneous Vagus Nerve Stimulation Modulates Default Mode Network in Major Depressive Disorder",
    "authors": "Fang et al.",
    "journal": "Biological Psychiatry",
    "year": 2016,
    "condition": "Depression",
    "studyType": "RCT",
    "subjects": 34,
    "keyFinding": "taVNS modulated functional connectivity in the default mode network and showed antidepressant effects, suggesting a central mechanism for its therapeutic action in depression.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/25963932/",
    "doi": "https://doi.org/10.1016/j.biopsych.2015.03.025",
    "stimulationType": "taVNS",
    "tags": ["depression", "fMRI", "taVNS", "neuroimaging", "default mode network"]
  },
  {
    "id": "study-010",
    "title": "Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial",
    "authors": "Dawson et al.",
    "journal": "The Lancet",
    "year": 2021,
    "condition": "Stroke Rehabilitation",
    "studyType": "RCT",
    "subjects": 108,
    "keyFinding": "VNS paired with rehabilitation significantly improved upper limb motor function compared to rehabilitation with sham stimulation in chronic stroke patients at 90 days.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/33894832/",
    "doi": "https://doi.org/10.1016/S0140-6736(21)00475-X",
    "stimulationType": "iVNS",
    "tags": ["stroke", "rehabilitation", "iVNS", "motor function", "neuroplasticity"]
  },
  {
    "id": "study-011",
    "title": "Non-invasive Vagal Nerve Stimulation Effects on Hyperarousal and Autonomic State in Patients with Posttraumatic Stress Disorder and History of Mild Traumatic Brain Injury: Preliminary Evidence",
    "authors": "Lamb et al.",
    "journal": "Frontiers in Medicine",
    "year": 2017,
    "condition": "PTSD",
    "studyType": "pilot",
    "subjects": 22,
    "keyFinding": "Non-invasive vagal nerve stimulation reduced PTSD symptom severity and showed promising effects on autonomic regulation in veterans with combat-related PTSD.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/28824913/",
    "doi": "https://doi.org/10.3389/fmed.2017.00124",
    "stimulationType": "taVNS",
    "tags": ["PTSD", "taVNS", "pilot", "veterans", "autonomic"]
  },
  {
    "id": "study-012",
    "title": "Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study",
    "authors": "Bonaz et al.",
    "journal": "Neurogastroenterology and Motility",
    "year": 2016,
    "condition": "Inflammation",
    "studyType": "pilot",
    "subjects": 7,
    "keyFinding": "Chronic VNS improved clinical and biological markers of Crohn's disease in 5 of 7 patients over 6 months, supporting the role of the cholinergic anti-inflammatory pathway.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/26920654/",
    "doi": "https://doi.org/10.1111/nmo.12792",
    "stimulationType": "iVNS",
    "tags": ["inflammation", "Crohn's disease", "iVNS", "cholinergic", "gut health"]
  },
  {
    "id": "study-013",
    "title": "Transcutaneous vagus nerve stimulation reduces spontaneous but not induced negative thought intrusions in high worriers",
    "authors": "Burger et al.",
    "journal": "Biological Psychology",
    "year": 2019,
    "condition": "Anxiety",
    "studyType": "RCT",
    "subjects": 97,
    "keyFinding": "taVNS reduced spontaneous negative thought intrusions in high worriers compared to sham stimulation, suggesting vagal afferent pathways may modulate anxiety-related rumination.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/30710565/",
    "doi": "https://doi.org/10.1016/j.biopsycho.2019.01.014",
    "stimulationType": "taVNS",
    "tags": ["anxiety", "worry", "taVNS", "RCT", "mental health"]
  },
  {
    "id": "study-014",
    "title": "Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial",
    "authors": "Premchand et al.",
    "journal": "Journal of Cardiac Failure",
    "year": 2014,
    "condition": "Heart Failure",
    "studyType": "pilot",
    "subjects": 60,
    "keyFinding": "Chronic VNS was safe and improved left ventricular ejection fraction, heart rate variability, and six-minute walk distance in patients with symptomatic heart failure.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/25187002/",
    "doi": "https://doi.org/10.1016/j.cardfail.2014.08.009",
    "stimulationType": "iVNS",
    "tags": ["heart failure", "iVNS", "cardiac", "autonomic", "ANTHEM-HF"]
  },
  {
    "id": "study-015",
    "title": "Direct and Transcutaneous Vagus Nerve Stimulation for Treatment of Tinnitus: A Scoping Review",
    "authors": "Yakunina & Nam",
    "journal": "Frontiers in Neuroscience",
    "year": 2021,
    "condition": "Tinnitus",
    "studyType": "scoping review",
    "subjects": null,
    "keyFinding": "Both direct and transcutaneous VNS show potential for tinnitus treatment, with evidence suggesting that VNS combined with sound therapy may reduce tinnitus severity.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/34122002/",
    "doi": "https://doi.org/10.3389/fnins.2021.680590",
    "stimulationType": "taVNS",
    "tags": ["tinnitus", "taVNS", "scoping review", "auditory", "sound therapy"]
  },
  {
    "id": "study-016",
    "title": "Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response",
    "authors": "Englot et al.",
    "journal": "Journal of Neurosurgery",
    "year": 2011,
    "condition": "Epilepsy",
    "studyType": "meta-analysis",
    "subjects": 3321,
    "keyFinding": "VNS reduced seizure frequency by at least 50% in approximately half of patients with drug-resistant epilepsy, with greater efficacy observed in generalised versus partial seizures.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/21838505/",
    "doi": "https://doi.org/10.3171/2011.4.JNS101909",
    "stimulationType": "iVNS",
    "tags": ["epilepsy", "iVNS", "meta-analysis", "drug-resistant", "seizure reduction"]
  },
  {
    "id": "study-017",
    "title": "The Impact of Auricular Vagus Nerve Stimulation on Pain and Life Quality in Patients with Fibromyalgia Syndrome",
    "authors": "Kutlu et al.",
    "journal": "BioMed Research International",
    "year": 2020,
    "condition": "Pain",
    "studyType": "RCT",
    "subjects": 60,
    "keyFinding": "Auricular VNS was evaluated alongside exercise therapy in fibromyalgia patients, with improvements observed in select quality-of-life subparameters over 4 weeks of treatment.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/32190684/",
    "doi": "https://doi.org/10.1155/2020/8656218",
    "stimulationType": "taVNS",
    "tags": ["pain", "fibromyalgia", "taVNS", "RCT", "quality of life"]
  },
  {
    "id": "study-018",
    "title": "Transcutaneous Cervical Vagal Nerve Stimulation in Patients with Posttraumatic Stress Disorder (PTSD): A Pilot Study of Effects on PTSD Symptoms and Interleukin-6 Response to Stress",
    "authors": "Bremner et al.",
    "journal": "Journal of Affective Disorders Reports",
    "year": 2021,
    "condition": "PTSD",
    "studyType": "pilot",
    "subjects": 25,
    "keyFinding": "Transcutaneous cervical VNS reduced PTSD symptom severity by 17% and attenuated interleukin-6 inflammatory responses to stress in patients with PTSD.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/34778863/",
    "doi": "https://doi.org/10.1016/j.jadr.2021.100190",
    "stimulationType": "tcVNS",
    "tags": ["PTSD", "tcVNS", "pilot", "inflammation", "IL-6"]
  },
  {
    "id": "study-019",
    "title": "Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity",
    "authors": "Clancy et al.",
    "journal": "Brain Stimulation",
    "year": 2014,
    "condition": "Anxiety",
    "studyType": "RCT",
    "subjects": 48,
    "keyFinding": "Transcutaneous VNS reduced muscle sympathetic nerve activity and shifted autonomic balance toward parasympathetic dominance in healthy volunteers, demonstrating a direct physiological mechanism for anxiolytic effects.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/25164906/",
    "doi": "https://doi.org/10.1016/j.brs.2014.07.031",
    "stimulationType": "taVNS",
    "tags": ["anxiety", "taVNS", "sympathetic", "healthy volunteers", "autonomic"]
  },
  {
    "id": "study-020",
    "title": "Effect of transcutaneous vagus nerve stimulation on muscle activity in the gastrointestinal tract (transVaGa)",
    "authors": "Hong et al.",
    "journal": "International Journal of Colorectal Disease",
    "year": 2019,
    "condition": "Gut Health",
    "studyType": "pilot",
    "subjects": 14,
    "keyFinding": "Transcutaneous auricular VNS modulated gastrointestinal muscle activity as measured by electromyography, supporting its therapeutic potential for gastrointestinal motility disorders.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/30519842/",
    "doi": "https://doi.org/10.1007/s00384-018-3204-6",
    "stimulationType": "taVNS",
    "tags": ["gut health", "taVNS", "gastrointestinal", "motility", "transVaGa"]
  },
  {
    "id": "study-021",
    "title": "A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: comparison of response, remission, and suicidality",
    "authors": "Aaronson et al.",
    "journal": "American Journal of Psychiatry",
    "year": 2017,
    "condition": "Depression",
    "studyType": "long-term study",
    "subjects": 795,
    "keyFinding": "Over 5 years, VNS plus treatment as usual produced significantly higher cumulative response rates (67.6% vs 40.9%) and remission rates (43.3% vs 25.7%) compared to treatment as usual alone in treatment-resistant depression.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/28359201/",
    "doi": "https://doi.org/10.1176/appi.ajp.2017.16010034",
    "stimulationType": "iVNS",
    "tags": ["depression", "iVNS", "treatment-resistant", "long-term", "registry"]
  },
  {
    "id": "study-022",
    "title": "Vagus-nerve stimulation for the treatment of epilepsy",
    "authors": "Ben-Menachem",
    "journal": "The Lancet Neurology",
    "year": 2002,
    "condition": "Epilepsy",
    "studyType": "narrative review",
    "subjects": null,
    "keyFinding": "Comprehensive review establishing VNS as an accepted treatment for refractory epilepsy, with efficacy that improves over 18-24 months and evidence of broad-spectrum antiseizure effects.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/12849332/",
    "doi": "https://doi.org/10.1016/s1474-4422(02)00220-x",
    "stimulationType": "iVNS",
    "tags": ["epilepsy", "iVNS", "review", "safety", "refractory seizures"]
  },
  {
    "id": "study-023",
    "title": "Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission",
    "authors": "Dorr & Debonnel",
    "journal": "Journal of Pharmacology and Experimental Therapeutics",
    "year": 2006,
    "condition": "Depression",
    "studyType": "preclinical",
    "subjects": null,
    "keyFinding": "VNS significantly increased the basal firing rates of both serotonergic neurons in the dorsal raphe nucleus and noradrenergic neurons in the locus coeruleus, suggesting a novel antidepressant mechanism of action.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/16690723/",
    "doi": "https://doi.org/10.1124/jpet.106.104166",
    "stimulationType": "iVNS",
    "tags": ["depression", "serotonin", "noradrenaline", "preclinical", "mechanism"]
  },
  {
    "id": "study-024",
    "title": "Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain",
    "authors": "Follesa et al.",
    "journal": "Brain Research",
    "year": 2007,
    "condition": "Neuroplasticity",
    "studyType": "preclinical",
    "subjects": null,
    "keyFinding": "Acute VNS increased the expression of BDNF and fibroblast growth factor in the hippocampus and cortex, and increased norepinephrine concentration in the prefrontal cortex, suggesting neuroplastic mechanisms.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/17920573/",
    "doi": "https://doi.org/10.1016/j.brainres.2007.08.045",
    "stimulationType": "iVNS",
    "tags": ["BDNF", "neuroplasticity", "preclinical", "norepinephrine"]
  },
  {
    "id": "study-025",
    "title": "Non-invasive access to the vagus nerve central projections via electrical stimulation of the external ear: fMRI evidence in humans",
    "authors": "Frangos et al.",
    "journal": "Brain Stimulation",
    "year": 2015,
    "condition": "Neuroimaging",
    "studyType": "RCT",
    "subjects": 12,
    "keyFinding": "Electrical stimulation of the cymba conchae activated classical central vagal projections including the NTS, locus coeruleus, and dorsal raphe, providing fMRI evidence that vagal afferents can be accessed non-invasively via the external ear.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/25573069/",
    "doi": "https://doi.org/10.1016/j.brs.2014.11.018",
    "stimulationType": "taVNS",
    "tags": ["neuroimaging", "fMRI", "taVNS", "brainstem", "mechanism"]
  },
  {
    "id": "study-026",
    "title": "Auricular transcutaneous electrical nerve stimulation in depressed patients: a randomized controlled pilot study",
    "authors": "Hein et al.",
    "journal": "Journal of Neural Transmission",
    "year": 2013,
    "condition": "Depression",
    "studyType": "RCT",
    "subjects": 37,
    "keyFinding": "Active auricular transcutaneous electrical nerve stimulation produced significantly greater improvement in Beck Depression Inventory scores compared to sham stimulation over two weeks in depressed patients.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/23117749/",
    "doi": "https://doi.org/10.1007/s00702-012-0908-6",
    "stimulationType": "taVNS",
    "tags": ["depression", "taVNS", "RCT", "pilot"]
  },
  {
    "id": "study-027",
    "title": "The efficacy and safety of transcutaneous auricular vagus nerve stimulation in the treatment of depressive disorder: a systematic review and meta-analysis of randomized controlled trials",
    "authors": "Tan et al.",
    "journal": "Journal of Affective Disorders",
    "year": 2023,
    "condition": "Depression",
    "studyType": "meta-analysis",
    "subjects": null,
    "keyFinding": "Pooled analysis of RCTs found that taVNS significantly reduced depression scores compared to sham stimulation, with moderate effect sizes and fewer side effects than antidepressants.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/37230264/",
    "doi": "https://doi.org/10.1016/j.jad.2023.05.040",
    "stimulationType": "taVNS",
    "tags": ["depression", "taVNS", "meta-analysis", "systematic review"]
  },
  {
    "id": "study-028",
    "title": "Transcutaneous auricular vagus nerve stimulation for post-stroke depression: a double-blind, randomized, placebo-controlled trial",
    "authors": "Liu et al.",
    "journal": "Journal of Affective Disorders",
    "year": 2024,
    "condition": "Depression",
    "studyType": "RCT",
    "subjects": null,
    "keyFinding": "taVNS combined with conventional treatment significantly improved depression scores in post-stroke depression patients compared to sham, expanding potential applications beyond primary MDD.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/38452937/",
    "doi": "https://doi.org/10.1016/j.jad.2024.03.005",
    "stimulationType": "taVNS",
    "tags": ["depression", "stroke", "taVNS", "RCT", "post-stroke"]
  },
  {
    "id": "study-029",
    "title": "Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation",
    "authors": "Manta et al.",
    "journal": "Journal of Psychiatry & Neuroscience",
    "year": 2009,
    "condition": "Depression",
    "studyType": "preclinical",
    "subjects": null,
    "keyFinding": "Sustained VNS initially increases noradrenergic neuron firing (after 1 day) and subsequently serotonergic neuron firing (after 14 days), representing a unique cascade antidepressant mechanism.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/19568478/",
    "doi": "https://doi.org/10.1139/jpn.0936",
    "stimulationType": "iVNS",
    "tags": ["depression", "serotonin", "noradrenaline", "preclinical", "mechanism"]
  },
  {
    "id": "study-030",
    "title": "Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial",
    "authors": "Rush et al.",
    "journal": "Biological Psychiatry",
    "year": 2005,
    "condition": "Depression",
    "studyType": "RCT",
    "subjects": 235,
    "keyFinding": "In the pivotal 10-week acute phase trial, active VNS produced a 15.2% response rate versus 10.0% for sham in treatment-resistant depression; the primary endpoint did not reach statistical significance.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/16139580/",
    "doi": "https://doi.org/10.1016/j.biopsych.2005.05.025",
    "stimulationType": "iVNS",
    "tags": ["depression", "iVNS", "RCT", "treatment-resistant", "FDA"]
  },
  {
    "id": "study-031",
    "title": "The inflammatory reflex",
    "authors": "Tracey",
    "journal": "Nature",
    "year": 2002,
    "condition": "Inflammation",
    "studyType": "narrative review",
    "subjects": null,
    "keyFinding": "Landmark review defining the 'inflammatory reflex' â€” a neural circuit by which the vagus nerve modulates the immune response, with cholinergic neurons inhibiting acute inflammation in real time.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/12490958/",
    "doi": "https://doi.org/10.1038/nature01321",
    "stimulationType": "iVNS",
    "tags": ["inflammation", "cholinergic anti-inflammatory pathway", "review", "landmark"]
  },
  {
    "id": "study-032",
    "title": "Transcutaneous auricular vagus nerve stimulation modulating the brain topological architecture of functional network in major depressive disorder: an fMRI study",
    "authors": "Guo et al.",
    "journal": "Brain Sciences",
    "year": 2024,
    "condition": "Depression",
    "studyType": "pilot",
    "subjects": 19,
    "keyFinding": "Four weeks of taVNS increased global efficiency and decreased characteristic path length in functional brain networks of MDD patients, with changes in network topology correlating with depression score improvements.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/39335439/",
    "doi": "https://doi.org/10.3390/brainsci14090945",
    "stimulationType": "taVNS",
    "tags": ["depression", "fMRI", "taVNS", "neuroimaging", "brain networks"]
  },
  {
    "id": "study-033",
    "title": "Optimization of transcutaneous vagus nerve stimulation using functional MRI",
    "authors": "Yakunina et al.",
    "journal": "Neuromodulation",
    "year": 2017,
    "condition": "Neuroimaging",
    "studyType": "RCT",
    "subjects": null,
    "keyFinding": "fMRI comparison of four ear stimulation locations found that the cymba conchae activated the vagal pathway most effectively, providing evidence for optimal taVNS electrode placement.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/27898202/",
    "doi": "https://doi.org/10.1111/ner.12541",
    "stimulationType": "taVNS",
    "tags": ["neuroimaging", "fMRI", "taVNS", "stimulation parameters", "optimisation"]
  },
  {
    "id": "study-034",
    "title": "Effects of transcutaneous vagus nerve stimulation in individuals aged 55 years or above: potential benefits of daily stimulation",
    "authors": "Bretherton et al.",
    "journal": "Aging",
    "year": 2019,
    "condition": "Ageing",
    "studyType": "RCT",
    "subjects": 29,
    "keyFinding": "Two weeks of daily taVNS improved autonomic balance, baroreflex sensitivity, and some aspects of quality of life, mood, and sleep in adults aged 55 and over.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/31358702/",
    "doi": "https://doi.org/10.18632/aging.102074",
    "stimulationType": "taVNS",
    "tags": ["ageing", "taVNS", "autonomic", "sleep", "HRV"]
  },
  {
    "id": "study-035",
    "title": "Transcutaneous auricular vagus nerve stimulation in insomnia: a systematic review and meta-analysis",
    "authors": "De Oliveira et al.",
    "journal": "Neuromodulation",
    "year": 2025,
    "condition": "Sleep",
    "studyType": "meta-analysis",
    "subjects": 336,
    "keyFinding": "Pooling data from six studies, taVNS significantly improved PSQI scores (MD = -3.60) and Insomnia Severity Index scores (MD = -5.24), with improvements across multiple sleep dimensions and minimal adverse effects.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/40323248/",
    "doi": "https://doi.org/10.1016/j.neurom.2025.04.001",
    "stimulationType": "taVNS",
    "tags": ["sleep", "insomnia", "taVNS", "meta-analysis", "systematic review"]
  },
  {
    "id": "study-036",
    "title": "Transcutaneous vagus nerve stimulation could improve the effective rate on the quality of sleep in the treatment of primary insomnia: a randomized control trial",
    "authors": "Wu et al.",
    "journal": "Brain Sciences",
    "year": 2022,
    "condition": "Sleep",
    "studyType": "RCT",
    "subjects": 30,
    "keyFinding": "One month of taVNS improved the effective rate of treatment for primary insomnia compared to sham, adding to evidence that taVNS produces clinically meaningful improvements in sleep quality.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/36291230/",
    "doi": "https://doi.org/10.3390/brainsci12101296",
    "stimulationType": "taVNS",
    "tags": ["sleep", "insomnia", "taVNS", "RCT"]
  },
  {
    "id": "study-037",
    "title": "Effects of transcutaneous auricular vagus nerve stimulation on brain functional connectivity of medial prefrontal cortex in patients with primary insomnia",
    "authors": "Zhang et al.",
    "journal": "Anatomical Record",
    "year": 2021,
    "condition": "Sleep",
    "studyType": "pilot",
    "subjects": null,
    "keyFinding": "taVNS altered functional connectivity of the medial prefrontal cortex in patients with primary insomnia, providing a neuroimaging correlate for the sleep-improving effects of vagal stimulation.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/34623769/",
    "doi": "https://doi.org/10.1002/ar.24785",
    "stimulationType": "taVNS",
    "tags": ["sleep", "insomnia", "taVNS", "neuroimaging", "fMRI"]
  },
  {
    "id": "study-038",
    "title": "Transcutaneous auricular vagus nerve stimulation for chronic insomnia disorder: a randomized clinical trial",
    "authors": "Zhang et al.",
    "journal": "JAMA Network Open",
    "year": 2024,
    "condition": "Sleep",
    "studyType": "RCT",
    "subjects": 72,
    "keyFinding": "Active taVNS achieved a mean PSQI reduction of 8.2 points versus 3.9 for sham (Cohen's d = 1.2) in chronic insomnia, with benefits sustained over 20 weeks and no serious adverse effects.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/39680406/",
    "doi": "https://doi.org/10.1001/jamanetworkopen.2024.51217",
    "stimulationType": "taVNS",
    "tags": ["sleep", "insomnia", "taVNS", "RCT", "JAMA"]
  },
  {
    "id": "study-039",
    "title": "Bilateral transcutaneous auricular vagus nerve stimulation for the treatment of insomnia in breast cancer",
    "authors": "Do et al.",
    "journal": "Scientific Reports",
    "year": 2025,
    "condition": "Sleep",
    "studyType": "pilot",
    "subjects": 20,
    "keyFinding": "Nightly bilateral taVNS over two weeks significantly reduced insomnia severity, improved sleep quality, decreased cancer-related fatigue and depression, and increased HRV in breast cancer patients.",
    "pubmedUrl": "https://www.nature.com/articles/s41598-025-30600-6",
    "doi": "https://doi.org/10.1038/s41598-025-30600-6",
    "stimulationType": "taVNS",
    "tags": ["sleep", "insomnia", "taVNS", "breast cancer", "pilot"]
  },
  {
    "id": "study-040",
    "title": "Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin",
    "authors": "Borovikova et al.",
    "journal": "Nature",
    "year": 2000,
    "condition": "Inflammation",
    "studyType": "preclinical",
    "subjects": null,
    "keyFinding": "Landmark discovery that electrical stimulation of the vagus nerve dramatically reduced TNF production and attenuated systemic inflammation in an endotoxemia model, establishing the cholinergic anti-inflammatory pathway.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/10839541/",
    "doi": "https://doi.org/10.1038/35013070",
    "stimulationType": "iVNS",
    "tags": ["inflammation", "preclinical", "landmark", "TNF", "endotoxin"]
  },
  {
    "id": "study-041",
    "title": "Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis",
    "authors": "Huston et al.",
    "journal": "Journal of Experimental Medicine",
    "year": 2006,
    "condition": "Inflammation",
    "studyType": "preclinical",
    "subjects": null,
    "keyFinding": "Splenectomy abolished the anti-inflammatory effect of cervical VNS, confirming that the spleen is the principal site of immune modulation in the cholinergic anti-inflammatory pathway.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/16785311/",
    "doi": "https://doi.org/10.1084/jem.20052362",
    "stimulationType": "iVNS",
    "tags": ["inflammation", "preclinical", "spleen", "cholinergic", "mechanism"]
  },
  {
    "id": "study-042",
    "title": "Manipulation of the inflammatory reflex as a therapeutic strategy",
    "authors": "Kelly et al.",
    "journal": "Cell Reports Medicine",
    "year": 2022,
    "condition": "Inflammation",
    "studyType": "narrative review",
    "subjects": null,
    "keyFinding": "Comprehensive review of how the inflammatory reflex operates through vagal and splenic nerve signalling to modulate macrophage cytokine production via alpha7 nicotinic receptors.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/35858588/",
    "doi": "https://doi.org/10.1016/j.xcrm.2022.100696",
    "stimulationType": "iVNS",
    "tags": ["inflammation", "review", "cholinergic anti-inflammatory pathway", "bioelectronic medicine"]
  },
  {
    "id": "study-043",
    "title": "The cholinergic anti-inflammatory pathway",
    "authors": "Pavlov & Tracey",
    "journal": "Brain, Behavior, and Immunity",
    "year": 2005,
    "condition": "Inflammation",
    "studyType": "narrative review",
    "subjects": null,
    "keyFinding": "Established that the efferent vagus nerve inhibits pro-inflammatory cytokine release through acetylcholine signalling at alpha7 nicotinic receptors, defining the cholinergic anti-inflammatory pathway.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/15922555/",
    "doi": "https://doi.org/10.1016/j.bbi.2005.03.015",
    "stimulationType": "iVNS",
    "tags": ["inflammation", "review", "cholinergic anti-inflammatory pathway", "acetylcholine"]
  },
  {
    "id": "study-044",
    "title": "No consistent evidence for the anti-inflammatory effect of vagus nerve stimulation in humans: a systematic review and meta-analysis",
    "authors": "Schiweck et al.",
    "journal": "Brain, Behavior, and Immunity",
    "year": 2024,
    "condition": "Inflammation",
    "studyType": "meta-analysis",
    "subjects": 1135,
    "keyFinding": "Meta-analysis of 26 studies found no consistent evidence for anti-inflammatory effects of VNS in humans, highlighting the gap between compelling preclinical data and more equivocal clinical results.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/38070618/",
    "doi": "https://doi.org/10.1016/j.bbi.2023.12.008",
    "stimulationType": "taVNS",
    "tags": ["inflammation", "meta-analysis", "cytokines", "systematic review"]
  },
  {
    "id": "study-045",
    "title": "Vagus nerve stimulation in autoimmune conditions: a systematic review",
    "authors": "Lombo et al.",
    "journal": "ACR Open Rheumatology",
    "year": 2025,
    "condition": "Inflammation",
    "studyType": "systematic review",
    "subjects": null,
    "keyFinding": "Across 12 clinical trials of VNS in autoimmune conditions, more than half found reductions in pro-inflammatory cytokines, with IL-6 most consistently reduced (6 of 7 studies).",
    "pubmedUrl": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12703127/",
    "doi": "https://doi.org/10.1002/acr2.70137",
    "stimulationType": "iVNS",
    "tags": ["inflammation", "autoimmune", "systematic review", "rheumatoid arthritis"]
  },
  {
    "id": "study-046",
    "title": "Transcutaneous vagus nerve stimulation has no anti-inflammatory effect in diabetes",
    "authors": "Okdahl et al.",
    "journal": "Scientific Reports",
    "year": 2024,
    "condition": "Inflammation",
    "studyType": "RCT",
    "subjects": 131,
    "keyFinding": "Transcutaneous cervical VNS did not reduce plasma concentrations of inflammatory cytokines (IL-6, IL-8, IL-10, TNF-alpha, IFN-gamma) in patients with diabetes over 56 days of treatment.",
    "pubmedUrl": "https://www.nature.com/articles/s41598-024-72139-y",
    "doi": "https://doi.org/10.1038/s41598-024-72139-y",
    "stimulationType": "tcVNS",
    "tags": ["inflammation", "diabetes", "tcVNS", "RCT", "negative result"]
  },
  {
    "id": "study-047",
    "title": "Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation",
    "authors": "Wang et al.",
    "journal": "Nature",
    "year": 2003,
    "condition": "Inflammation",
    "studyType": "preclinical",
    "subjects": null,
    "keyFinding": "Established that the nicotinic acetylcholine receptor alpha7 subunit is essential for inhibiting cytokine synthesis by the cholinergic anti-inflammatory pathway, identifying the critical receptor on macrophages.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/12508119/",
    "doi": "https://doi.org/10.1038/nature01339",
    "stimulationType": "iVNS",
    "tags": ["inflammation", "preclinical", "alpha7 receptor", "landmark", "mechanism"]
  },
  {
    "id": "study-048",
    "title": "Functional and chemical anatomy of the afferent vagal system",
    "authors": "Berthoud & Neuhuber",
    "journal": "Autonomic Neuroscience",
    "year": 2000,
    "condition": "Gut Health",
    "studyType": "narrative review",
    "subjects": null,
    "keyFinding": "Comprehensive anatomical review establishing that approximately 80% of vagal fibres are afferent, carrying sensory information from visceral organs to the brain, with the vagus innervating nearly the entire gastrointestinal tract.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/11189015/",
    "doi": "https://doi.org/10.1016/S1566-0702(00)00215-0",
    "stimulationType": "iVNS",
    "tags": ["anatomy", "vagus nerve", "review", "gut-brain axis", "afferent"]
  },
  {
    "id": "study-049",
    "title": "The vagus nerve at the interface of the microbiota-gut-brain axis",
    "authors": "Bonaz et al.",
    "journal": "Frontiers in Neuroscience",
    "year": 2018,
    "condition": "Gut Health",
    "studyType": "narrative review",
    "subjects": null,
    "keyFinding": "Review establishing the vagus nerve as a key communication pathway between gut microbes and the brain, with vagal afferents sensing microbial metabolites and the cholinergic anti-inflammatory pathway modulating intestinal inflammation.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/29467611/",
    "doi": "https://doi.org/10.3389/fnins.2018.00049",
    "stimulationType": "iVNS",
    "tags": ["gut health", "microbiome", "gut-brain axis", "review", "vagus nerve"]
  },
  {
    "id": "study-050",
    "title": "Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway",
    "authors": "de Jonge et al.",
    "journal": "Nature Immunology",
    "year": 2005,
    "condition": "Gut Health",
    "studyType": "preclinical",
    "subjects": null,
    "keyFinding": "VNS ameliorated surgery-induced inflammation and post-operative ileus by activating STAT3 in intestinal macrophages through alpha7 nicotinic receptor-mediated Jak2-STAT3 signalling.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/16025117/",
    "doi": "https://doi.org/10.1038/ni1229",
    "stimulationType": "iVNS",
    "tags": ["gut health", "inflammation", "preclinical", "post-operative ileus", "mechanism"]
  },
  {
    "id": "study-051",
    "title": "Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn's disease and irritable bowel syndrome",
    "authors": "Pellissier et al.",
    "journal": "PLoS ONE",
    "year": 2014,
    "condition": "Gut Health",
    "studyType": "pilot",
    "subjects": 73,
    "keyFinding": "Vagal tone was inversely correlated with TNF-alpha in Crohn's disease and with epinephrine in IBS, supporting the relevance of vagus nerve reinforcement interventions in inflammatory bowel conditions.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/25207649/",
    "doi": "https://doi.org/10.1371/journal.pone.0105328",
    "stimulationType": "iVNS",
    "tags": ["gut health", "Crohn's disease", "IBS", "vagal tone", "inflammation"]
  },
  {
    "id": "study-052",
    "title": "Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures",
    "authors": "Ben-Menachem et al.",
    "journal": "Epilepsia",
    "year": 1994,
    "condition": "Epilepsy",
    "studyType": "RCT",
    "subjects": 114,
    "keyFinding": "In the first major controlled trial of VNS for epilepsy (E03), high-stimulation VNS achieved a 24.5% median reduction in seizure frequency versus 6.1% in the low-stimulation group in drug-resistant partial seizures.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/8026408/",
    "doi": "https://doi.org/10.1111/j.1528-1157.1994.tb02482.x",
    "stimulationType": "iVNS",
    "tags": ["epilepsy", "iVNS", "RCT", "partial seizures", "pivotal trial"]
  },
  {
    "id": "study-053",
    "title": "Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response",
    "authors": "Elliott et al.",
    "journal": "Epilepsy & Behavior",
    "year": 2011,
    "condition": "Epilepsy",
    "studyType": "long-term study",
    "subjects": 436,
    "keyFinding": "At mean 5-year follow-up, 63.8% of patients achieved at least 50% seizure reduction, demonstrating that VNS efficacy progressively improves over years of treatment in drug-resistant epilepsy.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/21144802/",
    "doi": "https://doi.org/10.1016/j.yebeh.2010.10.017",
    "stimulationType": "iVNS",
    "tags": ["epilepsy", "iVNS", "long-term", "drug-resistant"]
  },
  {
    "id": "study-054",
    "title": "Transcutaneous auricular vagus nerve stimulation (ta-VNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial",
    "authors": "Yang et al.",
    "journal": "Neurotherapeutics",
    "year": 2023,
    "condition": "Epilepsy",
    "studyType": "RCT",
    "subjects": 150,
    "keyFinding": "At 20 weeks, the responder rate and relative seizure frequency reduction were significantly higher in the active taVNS group compared to controls, supporting non-invasive VNS for drug-resistant epilepsy.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/36995682/",
    "doi": "https://doi.org/10.1007/s13311-023-01353-9",
    "stimulationType": "taVNS",
    "tags": ["epilepsy", "taVNS", "RCT", "drug-resistant", "double-blind"]
  },
  {
    "id": "study-055",
    "title": "Peripheral control of hypersynchronous discharge in epilepsy",
    "authors": "Zabara",
    "journal": "Electroencephalography and Clinical Neurophysiology",
    "year": 1985,
    "condition": "Epilepsy",
    "studyType": "preclinical",
    "subjects": null,
    "keyFinding": "Seminal preclinical demonstration that vagus nerve stimulation could suppress experimentally induced seizure activity, providing the scientific foundation for the development of clinical VNS therapy.",
    "pubmedUrl": null,
    "doi": "https://doi.org/10.1016/0013-4694(85)90626-1",
    "stimulationType": "iVNS",
    "tags": ["epilepsy", "preclinical", "landmark", "seizure suppression", "historical"]
  }
]
